C4 Therapeutics, Inc. vs. Twist Bioscience Corporation Common Stock
CCCC
C4 Therapeutics, Inc.
$3.39 -0.73%
VS TWSTTwist Bioscience Corporation Common Stock
$166.99 +7.35%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| CCCC | TWST | |
|---|---|---|
| Market Cap | $417.06 million | $11.07 billion |
| Revenue (TTM) | $35.04 million | $431.80 million |
| Net Income (TTM) | $-101,416,000 | $-136,717,000 |
TWST leads on 2 of 3 size & scale factors.
Valuation
| CCCC | TWST | |
|---|---|---|
| Price / Book | 1.69 | 24.84 |
| Price / Sales | 11.90 | 25.64 |
CCCC leads on 2 of 2 valuation factors.
Profitability
| CCCC | TWST | |
|---|---|---|
| Net Margin | -289.44% | -31.66% |
| Return on Equity | -41.02% | -30.67% |
TWST leads on 2 of 2 profitability factors.
Risk & Sentiment
| CCCC | TWST | |
|---|---|---|
| Short Interest | 0.29% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: CCCC overview, CCCC financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.